Medicare Enrolled
Dr. Aaron Bush, MD
Cardiovascular Disease · Boca Raton, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bush from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bush? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bush
Dr. Aaron Bush is a cardiovascular disease in Boca Raton, FL, with 12 years in practice. Based on federal Medicare data, Dr. Bush performed 9,348 Medicare services across 6,295 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bush received a total of $31,944 from 53 pharmaceutical and/or device companies across 731 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bush is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice▲ Top 8% volume in FL$ $31,944 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,348
Medicare services
Top 8% in FL for cardiovascular disease
6,295
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~779 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 649 | $28 | $45 |
| Electrocardiogram (EKG), 12-lead | 613 | $11 | $55 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 548 | $20 | $96 |
| Office visit, established patient (30-39 min) | 541 | $96 | $140 |
| Blood draw (venipuncture) | 482 | $7 | $7 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 411 | $88 | $300 |
| Regadenoson injection (Lexiscan) for heart stress test | 400 | $43 | $80 |
| Hospital follow-up visit, high complexity | 362 | $97 | $145 |
| Office visit, established patient, complex (40-54 min) | 322 | $140 | $200 |
| Echocardiogram, transthoracic | 321 | $148 | $849 |
| Complete blood count (CBC) with differential | 306 | $8 | $25 |
| Comprehensive metabolic blood panel | 302 | $10 | $72 |
| Hemoglobin A1c test (diabetes monitoring) | 300 | $9 | $28 |
| Lipid panel (cholesterol and triglycerides) | 292 | $13 | $27 |
| Ultrasonic guidance for blood vessel access | 258 | $12 | $30 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 221 | $10 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 212 | $49 | $300 |
| Infusion, normal saline solution, 250 cc | 206 | $1 | $15 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 204 | $346 | $1,140 |
| Office visit, established patient (20-29 min) | 203 | $65 | $100 |
| Remote pacemaker/defibrillator monitoring, 90 days | 165 | $17 | $50 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 151 | $20 | $41 |
| Remote pacemaker monitoring, 90 days | 141 | $23 | $50 |
| Initial hospital admission, high complexity | 124 | $139 | $260 |
| Cardiac catheterization | 122 | $207 | $1,600 |
| New patient office visit, complex (60-74 min) | 99 | $170 | $250 |
| Self measured blood pressure measurements | 95 | $11 | $30 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 93 | $18 | $35 |
| Basic metabolic blood panel | 90 | $8 | $22 |
| Natriuretic peptide (heart and blood vessel protein) level | 88 | $38 | $70 |
| Ultrasound of both sides of head and neck blood flow | 86 | $120 | $251 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 67 | $79 | $180 |
| New patient office visit (45-59 min) | 65 | $127 | $200 |
| Coronary stent placement | 62 | $472 | $2,900 |
| Hospital discharge day management, 30 minutes or less | 60 | $66 | $110 |
| Insertion of heart rhythm monitor under skin | 55 | $3,463 | $6,500 |
| Ultrasound of heart with probe in esophagus, with report | 47 | $85 | $400 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 46 | $2 | $35 |
| Ultrasound of heart blood flow, valves and chambers | 43 | $14 | $60 |
| Ultrasound of heart, follow-up | 42 | $20 | $70 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 39 | $61 | $500 |
| Magnesium level test | 36 | $7 | $15 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 36 | $301 | $1,700 |
| Hospital follow-up visit, moderate complexity | 35 | $61 | $122 |
| Programming of dual lead pacemaker system | 31 | $29 | $65 |
| Repair of left upper heart chamber with implant with review by radiologist | 27 | $640 | $2,900 |
| Transitional care management services for problem of high complexity | 24 | $224 | $325 |
| Thyroid stimulating hormone (TSH) test | 21 | $16 | $40 |
| New patient office visit (30-44 min) | 21 | $78 | $130 |
| Transitional care management services for problem of at least moderate complexity | 20 | $165 | $300 |
| Removal of heart rhythm monitor from under the skin | 19 | $69 | $300 |
| Replacement of aortic valve through the skin and femoral artery | 19 | $656 | $4,000 |
| Ldl cholesterol level | 19 | $10 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 19 | $21 | $50 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 19 | $58 | $220 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 15 | $64 | $160 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 15 | $19 | $50 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 15 | $179 | $1,800 |
| Placement and subsequent removal of device to protect brain from embolism through catheter using imaging guidance | 13 | $116 | $280 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $239 | $1,600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.7% high complexity
12.1% medium
75.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$31,944
Total received (2018-2024)
Avg $4,563/year across 7 years
Top 11% in FL for cardiovascular disease
53
Companies
731
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,914 (81.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,857 (18.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$174 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$9,002
2023$4,972
2022$3,092
2021$3,460
2020$3,673
2019$4,953
2018$2,792
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$7,993
Abbott Laboratories
$5,801
Boston Scientific Corporation
$1,921
Medtronic Vascular, Inc.
$1,486
Penumbra, Inc.
$1,257
Amgen Inc.
$1,201
Novartis Pharmaceuticals Corporation
$1,049
ABIOMED
$965
Medical Device Business Services, Inc.
$936
E.R. Squibb & Sons, L.L.C.
$834
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$735
Janssen Pharmaceuticals, Inc
$661
Cardiovascular Systems Inc.
$621
PFIZER INC.
$618
BIOTRONIK INC.
$566
Astellas Pharma US Inc
$566
Philips Electronics North America Corporation
$524
CARDIVA MEDICAL, INC.
$390
Actelion Pharmaceuticals US, Inc.
$371
Biosense Webster, Inc.
$330
Boehringer Ingelheim Pharmaceuticals, Inc.
$302
AstraZeneca Pharmaceuticals LP
$295
BOSTON SCIENTIFIC CORPORATION
$261
Medtronic, Inc.
$211
Inari Medical, Inc.
$203
PORTOLA PHARMACEUTICALS, INC.
$165
Merck Sharp & Dohme LLC
$164
Chiesi USA, Inc.
$144
AngioDynamics, Inc.
$142
HeartFlow, Inc.
$135
Philips North America LLC
$125
SANOFI-AVENTIS U.S. LLC
$109
Kiniksa Pharmaceuticals International, plc
$104
Terumo Medical Corporation
$76
Kiniksa Pharmaceuticals, Ltd.
$76
Merck Sharp & Dohme Corporation
$58
Kowa Pharmaceuticals America, Inc.
$56
W. L. Gore & Associates, Inc.
$50
Alnylam Pharmaceuticals Inc.
$48
Bayer Healthcare Pharmaceuticals Inc.
$48
Lexicon Pharmaceuticals, Inc.
$47
CHIESI USA, INC.
$41
Kestra Medical Technology Services, Inc.
$40
Teleflex LLC
$34
Cardinal Health 200, LLC
$31
Cardinal Health 200 LLC
$28
HEARTFLOW, INC.
$26
ATRICURE, INC.
$25
Amarin Pharma Inc.
$21
Esperion Therapeutics, Inc.
$19
Ostial Corporation
$15
Shockwave Medical, Inc
$13
G Medical Diagnostic Services, Inc.
$12
Top 3 companies account for 49.2% of total payments
Associated products mentioned in payments ›
(4067) Tack Endo Sys BTK · (5027) Intact Vascular Und · (5044) MCOT · (5091) Amb Mon & Diag Und · (9281) Turbo Elite · (CM9) Amb Mon & Diag Und · AMPLATZER Occluders · ANDEXXA · ANGIOJET · ANGIOVAC · AVEIR · Accent Pacemaker · Allure Quadra RF CRT Pacemaker · AngioVac · Arcalyst · Assure WCD · BRILINTA · BodyGuardian · CAMZYOS · CARDIOFORM Septal Occluder · CARDIVA VASCADE 5F VCS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · CLEVIPREX 50MG/100ML · COMET · CONFIRM RX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · CardioMEMS HF System · Connectivity and Remote care · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · ESPRIT · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FFRct · FLASH MINI OSTIAL SYSTEM · FLASH OSTIAL SYSTEM · FLASH OSTIAL SYSTEM OTW · FLOWTRIEVER CATHETER · Fortify Assura · GALLANT · GENERAL THERAPIES · GENERAL THROMBECTOMY · GENERAL - STENTS · GENERAL - THERAPIES · GORE CARDIOFORM Septal Occluder · General - Therapies · General - Vascular Intervention · Gore Septal Occluder · HEARTRAIL · HeartWare HVAD · Hi-Torque Command guide wire · IGT D Peripheral · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · JOT DX · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LINQ II · LIVALO · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · Livalo · MANTA · MERLIN@HOME · MICRA · MITRACLIP · MULTAQ · NA · NAVITOR · NEXLETOL · NUVISION ICE CATHETER · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIS · Omnilink Elite vascular stent system · PASCAL · POWERFLEX Pro PTA Catheter · PRESSUREWIRE · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · RHYTHMIA · ROTABLATOR · RUBY Coil · Repatha · S · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SUPERA · SYNERGY · Supera peripheral stent system · Trilogy 100 · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · XIENCE SIERRA · Xience V coronary stent system
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (81%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $342 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
259
Per 100K population
17.2
County median income
$81,115
Nearest hospital
BOCA RATON REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bush is a clinical cardiology specialist, with above-average Medicare volume (top 8% in FL), and high industry engagement (low-engagement, top 11%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bush experienced with interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec?
Based on Medicare claims data, Dr. Bush performed 649 interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bush receive payments from pharmaceutical companies?
Yes. Dr. Bush received a total of $31,944 from 53 companies across 731 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bush's costs compare to other cardiovascular diseases in Boca Raton?
Dr. Bush's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bush) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Boca Raton
Browse cardiovascular diseases in Boca Raton ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology